세계의 이식형 원격 환자 모니터링(IRPM) 디바이스 시장 규모는 2023년 65억 달러, 2024년 76억 달러에서 예측 기간 중 CAGR 21.7%로 추이하며, 2029년말에는 203억 달러로 성장할 것으로 예측됩니다.
북미 시장은 2024년 27억 달러에서 19.5%의 CAGR로 추이하며, 2029년말에는 67억 달러로 성장할 것으로 예측됩니다. 아시아태평양 시장은 2024년 20억 달러에서 24.3%의 CAGR로 추이하며, 2029년말에는 59억 달러로 성장할 것으로 예측됩니다.
세계의 이식형 원격 환자 모니터링(IRPM) 디바이스 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회의 분석, 법규제 환경, 신규 기술 및 기술개발의 동향, 시장 규모 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 개요
제2장 시장 개요
- 개요
- PESTEL 분석
- Porter's Five Forces 분석
- 공급망 분석
제3장 시장 역학
- 시장 역학 개요
- 시장 성장 촉진요인
- 만성질환의 증가와 인구의 고령화
- 모바일 헬스 애플리케이션의 수요 증가
- 무선통신 기술의 향상
- 시장 성장 억제요인
- 데이터 프라이버시에 관한 우려
- 엄격한 정부 규제
- 시장 기회
- 신흥 시장
- 시장이 해결해야 할 과제
- 헬스케어 시스템과의 통합
제4장 규제 상황
제5장 신규 기술과 개발
- 이식형 원격 환자 모니터링(IRPM) 디바이스 시장에서의 신규 기술
- AI와 기계학습
- 나노테크놀러지 기반 디바이스
- 생체 적합성 재료
- 특허 분석
- 특허 : 연별
- 특허 : 주요 출원인별
- 특허 : 주요 오너별
- 특허 : 주요 발명자별
- 특허 : 관할별
제6장 시장 부문 분석
- 세분화 내역
- IRPM 디바이스 : 세계 시장
- 시장 분석 : 제품별
- 이식형 심혈관 모니터링 디바이스
- 이식형 뇌 모니터링 디바이스
- 위장 모니터링(스마트 필)
- 이식형 혈액 모니터링 디바이스
- 이식형 호흡 모니터링 디바이스
- 이식형 근골격 모니터링 디바이스
- 기타
- 시장 분석 : 적응증별
- 심혈관질환
- 뇌 장애
- 소화기 질환
- 당뇨병
- 만성 호흡기질환
- 근골격계 질환
- 기타
- 시장 분석 : 최종사용자별
- 병원·진료소
- 재택 헬스케어
- 기타
- 지역적 내역
- 시장 분석 : 지역별
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제7장 지속가능성 : IRPM 디바이스에서 ESG의 관점
- IRPM 디바이스 업계에서의 지속가능성
- ESG 데이터의 이해
- BCC에 의한 결론
제8장 경쟁 정보
- 개요
- IRPM 디바이스 제조업체의 주요 전략
- 유통 네트워크
- 제품 지도제작
제9장 부록
- 조사 방법
- 약어
- 전시
- 기업 개요
- ABBOTT
- AVERTIX MEDICAL INC.
- BIOTRONIK
- BOSTON SCIENTIFIC CORP.
- CARDIAC RMS
- DEXCOM INC.
- EBR SYSTEMS INC.
- ENDOTRONIX INC.
- INJECTSENSE INC.
- IMPULSE DYNAMICS
- MEDICO S.R.L.
- MEDTRONIC
- PROFUSA INC.
- QURA LLC.
- VITALCONNECT
KSA
The global market for implantable remote patient monitoring (IRPM) devices was valued at $6.5 billion in 2023. The market is expected to grow from $7.6 billion in 2024 to $20.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% from 2024 to 2029.
The North American market for IRPM devices is expected to grow from $2.7 billion in 2024 to $6.7 billion by the end of 2029, at a CAGR of 19.5% from 2024 to 2029.
The Asia-Pacific market for IRPM devices is expected to grow from $2.0 billion in 2024 to $5.9 billion by the end of 2029, at a CAGR of 24.3% from 2024 to 2029.
Report Scope
The current report provides detailed information about the market's implantable remote patient monitoring (IRPM) devices. It provides market projections through 2029 and market ranks for key players. The report details the market share of IRPM devices based on product, indication and end users. This market is segmented into implantable cardiovascular monitoring devices, implantable brain monitoring devices, gastrointestinal monitoring (smart pills), implantable hematological monitoring devices, implantable respiratory monitoring devices, implantable musculoskeletal monitoring devices and others based on product. Based on indication, the market is segmented into cardiovascular diseases, brain disorders, gastrointestinal diseases, diabetes, chronic respiratory diseases, musculoskeletal diseases, and others. By end user, the market is categorized into hospitals and clinics, home healthcare settings, and others. A detailed competitive landscape includes major players, market share and recent strategic developments.
Additionally, the report offers a regional analysis, breaking down market trends and growth prospects across different geographical areas. It includes market forecasts, consumer insights, and a thorough supply chain analysis, addressing distribution channels and key suppliers. By examining these elements, the report aims to provide a comprehensive view of the market's current state and future potential, assisting stakeholders in making well-informed decisions and identifying strategic opportunities within the IRPM devices industry.
Report Includes
- 32 data tables and 47 additional tables
- An overview of the global market for implantable remote patient monitoring (IRPM) devices
- Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Estimates of the market size and revenue forecast for the global market, and a corresponding market share analysis by product, indication, end user, and region
- Discussion of the underlying opportunities in the implantable remote patient monitoring devices market, with the integration of internet of things (IoT) and wireless technologies for the diagnosis and treatment of diseases
- Assessment of factors driving the industry's growth, current trends, market opportunities and restraints, and the technological advances that will shape the future market
- Market share analysis of the major global corporations, the competitive landscape, product developments, marketing strategies and revenue forecasts
- A discussion of the industry's ESG challenges and practices
- Emphasis on the increasingly stringent government regulations as well as the increasing adoption of miniaturized multi-sensing devices in chronic disease management and self-health management
- Latest information on mergers and acquisitions, partnerships, agreements, collaborations, and other strategic alliances
- Identification of the major stakeholders and analysis of recent developments and segmental revenues
- Profiles of the leading companies, including Boston Scientific Corp., Medtronic, Abbott Laboratories, Dexcom Inc., and Biotronik
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- PESTEL Analysis
- Political
- Economic
- Social
- Technological
- Environmental
- Legal
- Porter's Five Forces Analysis
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential for New Entrants
- Threat of Substitutes
- Competition in the Industry
- Supply Chain Analysis
- R&D, Product Design and Early Prototyping
- Regulatory Submissions and Approvals
- Raw Material Procurement
- Manufacturing IRPM Devices
- Distribution and Sales
- Post-Sales Services
Chapter 3 Market Dynamics
- Market Dynamics Overview
- Market Drivers
- Increasing Prevalence of Chronic Diseases and an Aging Population
- Growing Demand for mHealth Applications
- Improved Wireless Communication Technologies
- Market Restraints
- Data Privacy Concerns
- Stringent Government Regulations
- Market Opportunities
- Emerging Markets
- Market Challenges
- Integration with Healthcare Systems
Chapter 4 Regulatory Landscape
- Regulatory Framework
- United States
- European Union
- Japan
Chapter 5 Emerging Technologies and Developments
- Emerging Technologies in the IRPM Devices Market
- Artificial Intelligence and Machine Learning
- Nanotechnology-based Devices
- Biocompatible Materials
- Patent Analysis
- Patents by Year
- Patents by Top Applicant
- Patents by Top Owner
- Patents by Top Inventor
- Patents by Jurisdiction
Chapter 6 Market Segment Analysis
- Segmentation Breakdown
- IRPM Devices: Global Markets
- Market Analysis by Product
- Implantable Cardiovascular Monitoring Devices
- Implantable Brain Monitoring Devices
- Gastrointestinal Monitoring (Smart Pills)
- Implantable Hematological Monitoring Devices
- Implantable Respiratory Monitoring Devices
- Implantable Musculoskeletal Monitoring Devices
- Others
- Market Analysis by Indication
- Cardiovascular Diseases
- Brain Disorders
- Gastrointestinal Diseases
- Diabetes
- Chronic Respiratory Diseases
- Musculoskeletal Diseases
- Others
- Market Analysis by End User
- Hospital and Clinics
- Home Healthcare Settings
- Other End-users
- Geographic Breakdown
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 7 Sustainability: An ESG Perspective in IRPM Devices
- Sustainability in the IRPM Devices Industry
- Understanding the ESG Data
- Concluding Remarks from BCC
Chapter 8 Competitive Intelligence
- Overview
- Key Strategies for IRPM Devices Manufacturers
- Distribution Networks
- Product Mapping
Chapter 9 Appendix
- Methodology
- Abbreviations
- Sources
- Company Profiles
- ABBOTT
- AVERTIX MEDICAL INC.
- BIOTRONIK
- BOSTON SCIENTIFIC CORP.
- CARDIAC RMS
- DEXCOM INC.
- EBR SYSTEMS INC.
- ENDOTRONIX INC.
- INJECTSENSE INC.
- IMPULSE DYNAMICS
- MEDICO S.R.L.
- MEDTRONIC
- PROFUSA INC.
- QURA LLC.
- VITALCONNECT
